This scenario is less likely to occur with modulators of chromatin modification and protein turnover, as these compounds
are not known to induce immediate DNA damage. However, it has to be noted that not all cancer-inducing compounds are
also directly DNA-damaging (that is, mutagenic), as exemplified by the increased rate of breast cancer observed following postmenopausal hormone replacement therapy124